Detalhe da pesquisa
1.
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
Clin Cancer Res
; 29(24): 5047-5056, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819936